Avemar

藥物反應 Drug Interaction

維生素 C

已有學者利用帶有一些不同腫瘤細胞,包括肺癌、黑色素細胞瘤、腎胚細胞瘤、大腸癌的免疫抑制小鼠,研究AVEMAR單獨使用或與維生素C合併使用後對腫瘤生長及轉移的影響。結果顯示維生素C本身可抑制某些種類的腫瘤細胞轉移。合併使用AVEMAR及維生素C則對所有的腫瘤模組皆有抑制轉移的功效。然而對某些腫瘤模組,單獨使用AVEMAR反而比合併使用AVEMAR及維生素C得到更好的抑制轉移功效。這份結果暗示同時使用AVEMAR和維生素C可能會相互影響彼此的作用。(Hidvégi et al., 1998)

   
 

維生素C

Tamoxifen

細胞穩定藥物

 
   

Vitamin C

Variant of the Lewis lung carcinoma (3LL-HH), B16 melanoma, a rat nephroblastoma (RWT-M), and a human colon carcinoma xenograft (HCR25) in immunosuppressed mice were used to study the effects of Avemar alone and Avemar plus vitamin C on tumor growth and metastasis. Effects on metastases were studied both with the primary tumors intact and after their surgical removal. Vitamin C alone had a significant inhibitory effect on metastases in some of these tumor models but not in others. However, combined treatment with Avemar plus vitamin C administered simultaneously profoundly inhibited metastases in all tumor models.  Interestingly, in some tumor models, treatment with Avemar alone had a greater inhibitory effect on metastasis formation than did Avemar plus vitamin C. These observations suggested that when administrated together (in the form of the synchronous combined treatment) the two compounds (Avemar and vitamin C) are mutually and favorably influence each other’s effect. (Hidvégi et al., 1998)